Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers
Clinical Cardiology · 2026-02 · 49 (2)
DOI: 10.1002/clc.70257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 19.02.2026. Verfasst von Peter Bond und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Atherosclerosis, Androgens. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Anti-Doping Authority (Dopingautoriteit Nederland).
Abstract (Originalsprache)
Background
Androgen abuse among young men is a prevalent yet under recognized risk factor for atherosclerotic cardiovascular disease (ASCVD). Supraphysiological androgen exposure adversely affects lipoprotein profiles, blood pressure, and vascular function, potentially accelerating atherosclerosis even in otherwise healthy individuals. Conventional cardiovascular risk prediction models may underestimate risk in this population due to fluctuating biomarker profiles and other unaccounted risk‐increasing factors that are not captured in these models.
Objectives
To review the mechanisms by which androgen abuse contributes to ASCVD, to highlight limitations of traditional risk stratification tools in this population, and to propose tailored approaches to risk assessment and prevention.
Methods
Narrative review of epidemiological, imaging, and mechanistic studies examining cardiovascular risk factors and subclinical atherosclerosis in androgen abusers.
Results
Available evidence indicates that androgen abuse adversely affects lipid profiles, blood pressure, and vascular endothelial function, and is associated with increased subclinical atherosclerosis. Conventional risk prediction models may underestimate risk in this population due to young age, fluctuating biomarker profiles, and cumulative exposure effects not captured by standard algorithms.
Conclusions
Androgen abuse should be recognized as a cardiovascular risk‐enhancing factor in young men. Individualized risk assessment beyond traditional calculators may be warranted to guide preventive strategies in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands.
- Department of Internal Medicine, Zaandam Medical Centre, Zaandam, the Netherlands.
- Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands.
ORCID-Profile: Peter Bond
Förderung
- Dutch Anti-Doping Authority (Dopingautoriteit Nederland)
Zitieren
APA
Bond, P., Smit, D. L., Verdegaal, T., & de Ronde, W. (2026). Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers. Clinical Cardiology, 49(2). https://doi.org/10.1002/clc.70257
Vancouver
Bond P, Smit DL, Verdegaal T, de Ronde W. Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers. Clinical Cardiology. 2026;49(2). doi:10.1002/clc.70257
BibTeX
@article{Bond2026,
author = {Bond, Peter and Smit, Diederik L and Verdegaal, Tijs and de Ronde, Willem},
title = {Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {2},
doi = {10.1002/clc.70257}
}
EUVIMED